After domestic medical device manufacturers raised serious concerns over Gujarat’s new coronary stent pricing model, which ...

Advances in PCI over the past decade mean the procedure can now approximate results only previously achieved with open-heart bypass surgery, new data show.

Due to advancements spurred by AI/ML, the impact of digital health technology will grow. Data from the Department for Promotion of Industry and Internal Trade show that FDI in the medicines and ...

Drug-eluting stents (DES) are used to treat heart artery blockages. Under the updated price structure notified by the state ...

The coronary stent market in India has reached a crucial milestone, with a valuation of USD 843.8 million in 2023, reflecting a transformative shift in the country’s approach to cardiovascular ...

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they ...

The order says stents approved by the United States Food and Drug Adminis-tration will be priced at Rs 25,000 per stent, and ...

The USTR has raised alarms over India's price caps on coronary stents and high customs duties on drug formulations, arguing ...

NPPA allows stent manufacturers to revise prices by 1.74% based on WPI, ensuring compliance with DPCO regulations.

This decision to put off the differential pricing was taken during a meeting in Gandhinagar of the governing body of the ...

According to the new price notified by the drug price regulator, the ceiling price of Bare Mental Stents is Rs 10692.69 & ...